ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: Journal of Thoracic Oncology
Author(s): Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, Wu YL; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions.

This is an interesting document adding the proposals for the next edition of lung cancer staging. the changes are going to be quite significant : 

Recommended changes are as follows: to subclassify T1 into T1a (≤1 cm), T1b (>1 to ≤2 cm), and T1c (>2 to ≤3 cm); to subclassify T2 into T2a (>3 to ≤4 cm) and T2b (>4 to ≤5 cm); to reclassify tumors greater than 5 to less than or equal to 7 cm as T3; to reclassify tumors greater than 7 cm as T4; to group involvement of main bronchus as T2 regardless of distance from carina; to group partial and total atelectasis/pneumonitis as T2; to reclassify diaphragm invasion as T4; and to delete mediastinal pleura invasion as a T descriptor.

 

 

Source: JACC
Author(s): Mario Gaudino, David Taggart,; Hisayoshi Suma, John D. Puskas, Filippo Crea, Massimo Massetti

This is an expert commentary on the state of the art in this field together with an audio commentary also available on this link 

Source: New England Journal of Medicine
Author(s): Steven P. Sedlis, Pamela M. Hartigan, Koon K. Teo, David J. Maron, John A. Spertus, John Mancini, William Kostuk, Bernard R. Chaitman, Daniel Berman, Jeffrey D. Lorin, Marcin Dada, William S. Weintraub, and William E. Boden for the COURAGE Trial Investigators

This article reports on the long-term (up to 15 year) survival of patients who participated in the COURAGE trial. 

Source: VuMedi
Author(s): Michael Mack

A nice short demonstration from Michael Mack of his cannulation technique for minimally invasive AVR with femoral vein cannulation 

Source: VuMedi
Author(s): Thomas daniel

This is an interesting video documenting radiotracer labelld lung nodule incision of a small 10mm right upper lobe nodule that is really quite deep 

Source: Interact CardioVasc Thorac Surg
Author(s): Tine E. Philipsen, Valérie M. Collas, Inez E. Rodrigus, Rodrigo A. Salgado, Bernard P. Paelinck, Christiaan M. Vrints, and Johan M. Bosmans

The authors report on TAVI implantation through the brachiocephalic artery in patients without ideal femoral access. This approach is safe and feasible. The distance between access point and implant site is short, facilitating catheter manipulation and implantation itself.

Source: Eur J Cardiothorac Surg
Author(s): Marijke H. van der Meulen, Michiel Dalinghaus, Alexander P.W.M. Maat, Pieter C. van de Woestijne, M. van Osch, M. de Hoog, Ulrike S. Kraemer, and Ad J.J.C. Bogers

Results of the Dutch National Paediatric HTx Programme are presented. Eighteen of 43 eligible patients underwent implantation of a ventricular assist device. The authors provide a detailed description of the outcomes.

Source: Eur J Cardiothorac Surg
Author(s): Andreas Holzamer, Emanuel Sitka, Christian Hengstenberg, Christof Schmid, Kurt Debl, Lars Maier, Daniele Camboni, Oliver Husser, and Michael Hilker

Prediction of the implantation plane in transcatheter aortic valve implantation using a multislice computed tomography-based method is evaluated in 244 patients. The results reveal large interindividual differences

Source: Eur J Cardiothorac Surg
Author(s): Miguel Sousa-Uva, Stuart J. Head, Matthias Thielmann, Giuseppe Cardillo, Umberto Benedetto, Martin Czerny, Joel Dunning, Manuel Castella, Tomas Gudbjartsson, Neil Howell, Mark Hazekamp, Philippe Kolh, Friedhelm Beyersdorf, Domenico Pagano, and A. Pieter Kappetein

How to develop the perfect clinical guideline: Instructions by the European Association for Cardio-Thoracic Surgery (EACTS).

Source: New England Journal of Medicine
Author(s): Steven P. Sedlis, Pamela M. Hartigan, Koon K. Teo, David J. Maron, John A. Spertus, G.B. John Mancini, William Kostuk, Bernard R. Chaitman, Daniel Berman, Jeffrey D. Lorin, Marcin Dada, William S. Weintraub, and William E. Boden for the COURAGE Trial Investigators

The authors report on the extended follow-up of Courage Trial patients for up to 15 years.  In this trial, patients with chronic stable angina were randomized to medical therapy alone versus PCI plus medical therapy.  At extended follow-up, there was no difference in overall survival between the two treatment strategies.

Pages